Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06909006
What this trial is testing

Semaglutide Treatment in Type 1 Diabetes

Who this might be right for
Obesity in DiabetesObesity/TherapyType 1 Diabetes Mellitus (T1DM)+6 more
Nordsjaellands Hospital 122
Not applicableLooking for participantsNCT07806838
What this trial is testing

Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication

Who this might be right for
Obesity & OverweightMuscle Mass and StrengthMuscle Function
University of California, Los Angeles 75
Not applicableStudy completedNCT00551343
What this trial is testing

Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome

Who this might be right for
Prader-Willi Syndrome
Garvan Institute of Medical Research 20
Not applicableStudy completedNCT02879955
What this trial is testing

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Who this might be right for
Overweight
Hvidovre University Hospital 20
Not applicableStudy completedNCT05598008
What this trial is testing

Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

Who this might be right for
Sexual Desire
University Hospital, Basel, Switzerland 85
Testing effectiveness (Phase 2)Study completedNCT06897202
What this trial is testing

Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Who this might be right for
Obesity in DiabetesType 2 Diabetes Mellitus (T2DM)
Pfizer 133
Not applicableStudy completedNCT02691481
What this trial is testing

Diabetes-Specific Nutritional Formulas Versus Oatmeal

Who this might be right for
Type 2 Diabetes MellitusObesity
Joslin Diabetes Center 25
Large-scale testing (Phase 3)Study completedNCT01468181
What this trial is testing

LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 394
Not applicableNot Yet RecruitingNCT06764056
What this trial is testing

Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated-dysfunction Steatohepatitis (MASH)Obesity
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 120
Testing effectiveness (Phase 2)Study completedNCT05895643
What this trial is testing

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?

Who this might be right for
Alcohol AbuseAlcohol AddictionAlcohol Dependence+1 more
Psychiatric Centre Rigshospitalet 108
Not applicableStudy completedNCT01305291
What this trial is testing

Fibersol-2 Clinical Trials Related to Appetite

Who this might be right for
Lack of Satiety
Iowa State University 20
Large-scale testing (Phase 3)Ended earlyNCT04741074
What this trial is testing

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Who this might be right for
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more
Geisinger Clinic 15
Not applicableStudy completedNCT05903482
What this trial is testing

Gastric Volume in Patients on GLP-1 Medications

Who this might be right for
Diabetes
Children's Hospital of Philadelphia 70
Not applicableEnrolling By InvitationNCT06924697
What this trial is testing

Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2Nicotine Dependence, Cigarettes
Shanghai East Hospital 46
Not applicableNot Yet RecruitingNCT07784127
What this trial is testing

Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation

Who this might be right for
Diabetes
The Cleveland Clinic 20
Not applicableStudy completedNCT03697486
What this trial is testing

The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1,Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women

Who this might be right for
PYYGhrelinAppetite+3 more
Universitas Indonesia 22
Early research (Phase 1)Study completedNCT00980083
What this trial is testing

GLP-1 - Regulatory Mechanism of Postprandial Glycemia

Who this might be right for
Healthy SubjectsGastric Emptying
Ludwig-Maximilians - University of Munich 12
Not applicableStudy completedNCT07096739
What this trial is testing

Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1

Who this might be right for
GLP-1 Concentration
Kate Farms Inc 20
Not applicableStudy completedNCT03835013
What this trial is testing

Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers

Who this might be right for
Cardiovascular Diseases
Cambridge University Hospitals NHS Foundation Trust 26
Large-scale testing (Phase 3)Study completedNCT02664441
What this trial is testing

Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

Who this might be right for
Hypothalamic Obesity
Seattle Children's Hospital 42
Next Page